Letter

Suicide risk

Bipolarity is important during treatment with antidepressants

BMJ 2007; 334 doi: 10.1136/bmj.39121.846667.1F (Published 15 February 2007)
Cite this as: BMJ 2007;334:327.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Daniel J Smith (smithdj3@cardiff.ac.uk),
  2. James T Walters, clinical lecturer
  1. Cardiff University, Cardiff CF14 4XN

    Rubino et al have identified that most (if not all) of the excess risk of suicide in a group of patients treated with venlafaxine could be explained by a higher burden of risk factors for suicide.1 It may be true that this group of patients had more severe or “difficult to …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular